clinical trial · NCT07446153
A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects
Jiangsu HengRui Medicine Co., Ltd.·phase2·recruiting·n = 282
Solid TumorHRS-8364 Tablet
brief summary
This study is an open, multicenter, Phase I/II clinical trial, divided into three stages: dose escalation, dose expansion and efficacy expansion.
started
Mar 19, 2026
primary completion
Dec 1, 2028
completion
Dec 1, 2029
last updated
Apr 3, 2026
official title
An Open Label, Multicenter Phase I/II Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol